Watch the interview!
Disclaimer
This case report and/or content does not reflect the opinion of iHF or iheartfunction.com, nor does it engage their responsibility.
Why and how to look for cardiac amyloidosis before TAVI?
Valve disease
Interview
Cardiac amyloidosis is increasingly recognised in patients with aortic stenosis, with a prevalence reaching up to 20%. This association has major implications for prognosis and management, making early identification a critical step in heart team decision-making, particularly in patients referred for TAVI.
In this interview, Emanuele Barbato and Giuseppe Rosano discuss why diagnosing amyloidosis is not merely an academic exercise, but a key determinant of whether and how patients should be treated.
They outline the extracardiac “red flags” that should be considered to raise suspicion of cardiac amyloidosis before TAVI, as well as the clinical tests required to confirm the diagnosis.
